NORTHWEST BIOTHERAPEUTICS INC

OTC:NWBO

Pharmaceutical Preparations·BETHESDA, MD

Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer.

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/9/24	→
↓

News (8-K)

80 shown

Filed	Type	Description
1/15/26	Other	Other Events	→
1/2/26	Vote	Amendments to Articles of Incorporation or Bylaws	→
11/20/25	Agreement	Entry into a Material Definitive Agreement	→
10/31/25	Agreement	Entry into a Material Definitive Agreement	→
10/30/25	Agreement	Entry into a Material Definitive Agreement	→
10/24/25	Other	Other Events	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
11/25/25	424B5	424B5	→
10/24/25	S-3	S-3	→
7/1/25	424B5	424B5	→
12/26/24	424B5	424B5	→
10/18/22	S-3	S-3	→
10/13/20	424B5	424B5	→
↓

Filing History(791 filings)

TypeDateAccessionPeriodSize

8-K

Jan 15, 2026

0001104659-26-004146FORM 8-K

Jan 15, 2026

183.1 KB

8-K

Jan 2, 2026

0001104659-26-000243FORM 8-K

Dec 29, 2025

432.8 KB

DEF 14A

Nov 28, 2025

0001104659-25-116966FORM DEF 14A

Dec 29, 2025

2.8 MB

EFFECT

Nov 25, 2025

9999999995-25-003389

—

1.7 KB

424B5

Nov 25, 2025

0001104659-25-116045424B5

—

352.6 KB

8-K

Nov 20, 2025

0001104659-25-114627FORM 8-K

Nov 14, 2025

182.0 KB

PRE 14A

Nov 19, 2025

0001104659-25-114107FORM PRE 14A

Dec 29, 2025

2.6 MB

10-Q

Nov 14, 2025

0001104659-25-11267610-Q

Sep 30, 2025

10.1 MB

8-K

Oct 31, 2025

0001104659-25-104812FORM 8-K

Oct 27, 2025

183.2 KB

8-K

Oct 30, 2025

0001104659-25-104427FORM 8-K

Oct 24, 2025

182.5 KB

8-K

Oct 24, 2025

0001104659-25-102049FORM 8-K

Oct 23, 2025

179.9 KB

S-3

Oct 24, 2025

0001104659-25-101916FORM S-3

—

1.5 MB

8-K

Oct 14, 2025

0001104659-25-099196FORM 8-K

Oct 9, 2025

182.1 KB

10-Q

Aug 14, 2025

0001410578-25-00182510-Q

Jun 30, 2025

9.9 MB

424B5

Jul 1, 2025

0001104659-25-064804424B5

—

376.0 KB

10-Q

May 15, 2025

0001410578-25-00133310-Q

Mar 31, 2025

9.1 MB

10-K

Mar 31, 2025

0001410578-25-00059810-K

Dec 31, 2024

15.0 MB

424B5

Dec 26, 2024

0001104659-24-131746424B5

—

341.9 KB

8-K

Dec 26, 2024

0001104659-24-131723FORM 8-K

Dec 19, 2024

219.3 KB

10-Q

Nov 12, 2024

0001410578-24-00187910-Q

Sep 30, 2024

10.4 MB

8-K

Nov 1, 2024

0001104659-24-113553FORM 8-K

Oct 31, 2024

190.1 KB

Sep 3, 2024

0001104659-24-096354OWNERSHIP DOCUMENT

Aug 29, 2024

5.3 KB

Aug 13, 2024

0001104659-24-088927OWNERSHIP DOCUMENT

Aug 9, 2024

5.3 KB

10-Q

Aug 9, 2024

0001410578-24-00127810-Q

Jun 30, 2024

10.0 MB

Aug 8, 2024

0001104659-24-087304OWNERSHIP DOCUMENT

Aug 8, 2024

5.3 KB

25 filings shown

NORTHWEST BIOTHERAPEUTICS INC

Financials

News (8-K)

Prospectuses & Registrations

Filing History(791 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
11/28/25	DEF 14A	DEF 14A	→
11/19/25	PRE 14A	FORM PRE 14A	→
6/25/24	DEFA14A	DEFA14A	→
6/3/24	DEF 14A	DEF 14A	→
5/22/24	PRE 14A	PRE 14A	→
12/23/22	DEFA14A	DEFA14A	→
↓

Filed	Form	Description
9/3/24	4	OWNERSHIP DOCUMENT	→
8/13/24	4	OWNERSHIP DOCUMENT	→
8/8/24	4	OWNERSHIP DOCUMENT	→
7/30/24	4	OWNERSHIP DOCUMENT	→
12/1/23	4	OWNERSHIP DOCUMENT	→
4/5/23	4	OWNERSHIP DOCUMENT	→
↓